Damora Therapeutics, Inc.
DMRA- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
近 90 天，Damora Therapeutics, Inc. 內部人申報 1 筆公開市場買進、0 筆賣出；2026 年第 2 季末有 104 家機構在 13F 申報持有，市值合計 $16.7 億；大師中只有維京全球投資持有。
SEC 申報
Damora Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/4 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/8/10 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/7/20 | 8-K | 1.013.035.037.019.01 | 2026/7/16 | SEC | 目錄 |
| 2026/6/17 | 8-K | 5.07 | 2026/4/28 | SEC | 目錄 |
| 2026/5/12 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/4 | 8-K | 5.029.01 | 2026/4/28 | SEC | 目錄 |
| 2026/4/20 | 8-K | 4.019.01 | 2026/4/17 | SEC | 目錄 |
| 2026/3/23 | 8-K | 5.027.019.01 | 2026/3/20 | SEC | 目錄 |
| 2026/3/19 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/10 | 8-K | 2.025.037.019.01 | 2026/3/6 | SEC | 目錄 |
| 2026/2/11 | 8-K | 1.019.01 | 2026/2/10 | SEC | 目錄 |
| 2026/2/10 | 8-K | 5.025.038.019.01 | 2026/2/6 | SEC | 目錄 |
| 2026/1/12 | 8-K | 7.019.01 | 2026/1/12 | SEC | 目錄 |
| 2026/1/6 | 8-K | 3.025.029.01 | 2025/12/31 | SEC | 目錄 |
| 2025/12/9 | 8-K/A | 5.039.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/10 | 8-K | 1.012.013.025.025.037.019.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/6 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/8/5 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/6/20 | 8-K | 5.07 | 2025/6/18 | SEC | 目錄 |
| 2025/5/8 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/3/19 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2024/11/1 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/10/15 | 8-K | 5.029.01 | 2024/10/15 | SEC | 目錄 |
| 2024/10/7 | 8-K | 1.012.013.025.025.037.019.01 | 2024/10/7 | SEC | 目錄 |
| 2024/9/18 | 8-K | 8.01 | 2024/9/16 | SEC | 目錄 |
| 2024/9/11 | 8-K | 8.01 | 2024/9/10 | SEC | 目錄 |
| 2024/9/5 | 8-K | 5.039.01 | 2024/8/29 | SEC | 目錄 |
| 2024/8/12 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/6/21 | 8-K | 5.07 | 2024/6/20 | SEC | 目錄 |
| 2024/4/29 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/3/26 | 8-K | 8.01 | 2024/3/22 | SEC | 目錄 |
| 2024/3/8 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2023/12/21 | 8-K | 8.019.01 | 2023/12/21 | SEC | 目錄 |
| 2023/11/6 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/10/23 | 8-K | 8.019.01 | 2023/10/23 | SEC | 目錄 |
| 2023/10/2 | 8-K | 3.01 | 2023/9/27 | SEC | 目錄 |
| 2023/9/26 | 8-K | 2.055.028.019.01 | 2023/9/20 | SEC | 目錄 |
| 2023/8/15 | 8-K | 7.018.019.01 | 2023/8/15 | SEC | 目錄 |
| 2023/7/31 | 10-Q | – | 2023/6/30 | SEC | 目錄 |
| 2023/6/15 | 8-K | 5.07 | 2023/6/14 | SEC | 目錄 |
| 2023/4/28 | 10-Q | – | 2023/3/31 | SEC | 目錄 |
| 2023/3/10 | 8-K | 7.01 | 2023/3/10 | SEC | 目錄 |
| 2023/3/9 | 10-K | – | 2022/12/31 | SEC | 目錄 |
| 2023/1/6 | 8-K | 2.027.019.01 | 2023/1/6 | SEC | 目錄 |
| 2022/11/8 | 10-Q | – | 2022/9/30 | SEC | 目錄 |
| 2022/10/31 | 8-K | 7.019.01 | 2022/10/31 | SEC | 目錄 |
| 2022/9/29 | 8-K | 7.018.019.01 | 2022/9/29 | SEC | 目錄 |
| 2022/7/29 | 10-Q | – | 2022/6/30 | SEC | 目錄 |
| 2022/6/17 | 8-K | 5.07 | 2022/6/14 | SEC | 目錄 |
| 2022/4/29 | 10-Q | – | 2022/3/31 | SEC | 目錄 |